Skip to main content
. Author manuscript; available in PMC: 2014 Oct 17.
Published in final edited form as: Sci Transl Med. 2013 Aug 14;5(198):198ra108. doi: 10.1126/scitranslmed.3006070

Table 1. Summary of study design.

Number of patients, doses of hyperpolarized [1-13C]pyruvate given, and types of MR examinations performed in each component of the study are provided.

Study component Dose (ml/kg) n patients Type of MR acquisition
Phase 1: Dose escalation 0.14 3 1D dynamic MRSI
3 3D MRSI
0.28 3 1D dynamic MRSI
3 3D MRSI
0.43 3 1D dynamic MRSI
3 2D MRSI
Phase 2: Refining MR methods 0.43 5 2D dynamic MRSI
3 2D MRSI
5 3D MRSI